FACT II Acquisition Corp. (FACTW)

Entity Type	SPAC (blank-check company)
Warrant Ticker	FACTW
What FACTW Is	Right to buy one share of common stock at a fixed strike price
Expiration	Typically 5 years from IPO or upon merger close
Strike Price	Usually $11.50 per share (standard SPAC warrant)
Intrinsic Value	Zero if common stock trades below strike; dollar-for-dollar above
Time Value	Decays toward expiration; becomes zero if expired in-the-money
SEC CIK	0002028935

FACTW is a warrant ticket representing leveraged exposure to FACT II Acquisition Corp., the SPAC itself. A warrant is a derivative security — a contract that grants its holder the right (but not the obligation) to purchase a share of the underlying stock at a preset price, called the strike. For a typical SPAC warrant, that right is to buy one share of common stock at $11.50 per share. The warrant holder pays nothing to exercise; they simply deliver the strike price and receive one share. Warrants are bundled with SPAC common stock in the initial offering (as units) and then separate and trade independently.

How SPAC warrants differ from the common shares

When you buy FACTW, you are not buying equity in FACT II Acquisition Corp. — you are buying a bet on the common stock (the SPAC unit shares) moving above the strike price. If the common stock trades at $10 per share, FACTW warrants are worthless (they give you the right to pay $11.50 for a share worth $10, which you would never exercise). If the common stock trades at $15 per share, FACTW warrants are worth at least $3.50 (the intrinsic value: $15 minus $11.50). In between, warrants have time value — the possibility that they will be in-the-money before expiration.

This leverage is both the appeal and the danger. A 50-percent move in the common stock can produce a 200-percent or 300-percent move in the warrant value, because the warrant’s value is the delta between the common price and the strike, plus or minus time decay. Retail investors often buy warrants thinking they are getting a leveraged bet on the SPAC, not realizing how quickly the time value erodes and how sensitive warrants are to the speed of price movement. If you buy FACTW at $1.50 and the common stock rises slowly to $12.50 (in-the-money), but two years pass, the warrant value may have collapsed to $0.80 due to time decay, even though the underlying common stock moved $2.50 in your favor.

The SPAC warrant economics

SPAC warrants have a crucial feature: they are often subject to redemption by the SPAC sponsor at a nominal price (often $0.01) if the warrant is in-the-money for a set period after merger close. This redemption right allows sponsors to eliminate warrants and avoid future dilution — effectively stealing the time value from warrant holders by forcing them to exercise before expiration or lose the security entirely. Many SPAC warrant holders have been blindsided by redemption announcements that forced them to either pony up strike price to exercise (locking in losses if the stock has fallen) or abandon the warrant entirely.

Warrant pricing in the SPAC world is also prone to manipulation and mispricing. Because warrant volume is often thin (especially for later-stage SPACs after redemptions), bid-ask spreads widen dramatically, and prices can move on minimal volume. Retail investors chasing warrants in hopes of outsized leverage often end up overpaying at peaks and forced to sell at losses in valleys.

The path to worthlessness

FACTW has an expiration date (typically five years from the SPAC’s IPO, or upon merger close if the merger happens first). Any warrant that has not been exercised by that date becomes worthless. If FACTW is purchased when the common stock is at $10 per share and never rises above $11.50 before expiration, the warrant owner will lose the entire investment — 100 percent loss — while the common-stock owner at least retains their equity stake in whatever entity emerges from the SPAC merger. This asymmetric risk profile means that FACTW is suitable only for investors who understand warrants thoroughly and can afford total loss without harm.

Researching FACTW

Anyone holding or considering FACTW should read the SPAC prospectus (filed as form S-1 on SEC EDGAR, using CIK 0002028935) to understand the warrant terms, the redemption provisions, and the sponsor’s track record. The prospectus discloses the warrant strike price, the expiration date, any adjustment mechanisms, and crucially, the sponsor’s redemption rights. Any subsequent merger proxy statement (filed when a deal is announced) will detail the post-merger status of the warrants and whether they survive the merger or are redeemed. A warrant holder who does not read these documents is flying blind.

The practical reality is simple: FACTW is a high-risk, time-decay asset suitable for sophisticated options traders and nobody else. Retail investors in SPAC warrants routinely lose money because they do not understand the mechanics of time decay, the risk of sponsor redemption, or the leverage and volatility that comes with a derivative security. The expected return on FACTW is negative for most holders. SEC CIK 0002028935 is the filing source; the prospectus and any merger proxy are the essential documents. Anyone else should avoid this security altogether.